In this review, the authors re-examine the role of aspirin in the primary prevention of cardiovascular disease. They discuss the history of the use of aspirin in primary prevention, the current guidelines, and the recent evidence surrounding aspirin use as primary prevention in special populations such as those with moderate cardiovascular risk, diabetes mellitus, and the elderly.
|Number of pages||4|
|Journal||Israel Medical Association Journal|
|State||Published - 2020|
- Cardiovascular disease
- Primary prevention